Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001193125-26-294697

Options or other derivatives

  • Director acquired 32,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gould Robert J Director 2026-06-30 Grant or award · Stock Option (right to buy) +32,000 32,000 D: show line 1 in the form
Loading xslF345X06/ownership.xml…